Event List

EHTEL's second Imagining 2029* webinar. This virtual meeting is part of the EHTEL Innovation Initiative agenda for 2020 on Exploring Digital Therapeutics, Artificial Intelligence, and Virtual Coaches.

"DIGITAL BIOMARKERS ARE DEFINED AS OBJECTIVE, QUANTIFIABLE PHYSIOLOGICAL AND BEHAVIORAL DATA THAT ARE COLLECTED AND MEASURED BY MEANS OF DIGITAL DEVICES SUCH AS PORTABLES, WEARABLES, IMPLANTABLES OR DIGESTIBLES. THE DATA COLLECTED IS TYPICALLY USED TO EXPLAIN, INFLUENCE AND/OR PREDICT HEALTH-RELATED OUTCOMES. DIGITAL BIOMARKERS ALSO REPRESENT AN OPPORTUNITY TO CAPTURE CLINICALLY MEANINGFUL, OBJECTIVE DATA." DIGITAL BIOMARKERS JOURNAL

The patient centric benefits of electronic informed consenting (eConsent) technologies have been well documented, from the provision of better educational mechanisms of informing patients and overall improved comprehension of the study.